Now available

Utibron Neohaler®

A combination LABA/LAMA dry-powder inhaler for maintenance treatment of COPD, including chronic bronchitis and/or emphysema.

UTIBRON NEOHALER combines a long-acting beta2-agonist, or LABA, medicine (indacaterol) and an anticholinergic medicine (glycopyrrolate). UTIBRON NEOHALER is used long term, twice each day (morning and evening), to treat the symptoms of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Get support and savings with Sunovion Answers for UTIBRON NEOHALER

Get Savings Card

LABA = long-acting beta2-agonist; LAMA = long-acting muscarinic antagonist, also called an anticholinergic.

How to use the

See information

Sunovion Answers can help you with medical information and insurance questions about the UTIBRON NEOHALER

Learn More
Sunovion Answers